{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07037433","recordId":"NCT07037433","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07037433-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07037433.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07037433.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-06-16","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"5098ac8d775597d71d55c58505fb31100267bda9c7620067d50dd747115c1664","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-07-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-18","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"2be3f28f0a18187bdb7159c3124f7039a6af926094025a3a949beefc8aa0354a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-24","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"22860f23d16dc8ae8312a463faf92d3250110d7b6a03a6275f19bf8f1563d50c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-06","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"9c2b406483d51331096afcde64eb8547f39f905c676d9e04388b21de8f32a149","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-08-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-13","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"ea1d65bdc29c0c20f6f2136daac7794d7293d65a999e752687dd68d6f167c682","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-08-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-27","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"7793d29451e832daaabf4d80174ff8d2ad96d9b9c62d2e33a7f87175fb1bd1ef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-09-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-03","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"d4a4b677405d58bef2b2175d325196290fbc383278ca93685909b232e9602f11","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2025-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-10","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"6aff043c72687935883c0b21b152f4147eafe1c9eb7bb380164cf8251634ced3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2025-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-17","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"b55b9938b01df9a5a3005e4602e25d0cf1742b247f5de1a3a478193a23399677","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2025-09-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-24","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"4d10b44aca9c6197c0e654c965473335408464b8ca6f08b64580f7278fbb2ff5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-07","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"33671c4fd9be5456f725e854bdbc37a45da69cb7eb62e4886ccb36887bdefe3a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2025-11-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-01","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"828578ead71f9cf96d7acefa4dea903f1bde027f6136313f08eae5cbdd911863","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2025-11-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-12","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"98b418299d58528be38d0278097fe202b9f5de62a6fec2f834bd7304be016d51","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-12-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-31","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"1441d5e00106c08545a1d66dca3e9772c2742dbe42f659e239fefce47f84e8e1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-01-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-21","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"acb40e6908c2a12e470d38b1e30b3eb36181d517a4dc2cf96303592bf8c29c61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-28","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"e7d4a14e066891e527c00a262768f6bc48b3ce22ca55b0868531748f475023a5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2026-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-11","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"1c3471f32666d604fc762c6a9c4eb440af83c0abce2ea4184d2f474b8655acd8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","IPDSharing","Outcome Measures","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2026-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-24","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"ca7b52b1a376ff47e72820bfde4ed4bc7bb908f9025ba7ef613462c65f1571d2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2026-04-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-17","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"a704a0ffa71a8ed64bbd9226744452a66b3c69b4d26ac18e511a8875eb335b02","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2026-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-22","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"d8cb206edc879b1110ad1940c84a3f365a0ef98eb93e4baf65eced02fcbb12fe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2026-05-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-07","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"83c0b2a861722802cbe4547bdd91fca1a557cf18e50af3156c30fd41322e439c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"9b5083aa0ee7ab86e574068050a5315d9ffeeb6fba449604288da128f4978235","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"18ab552bad7e70788dc5c402e0b58d08e391c826c095872eefce9664a812ebc6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2026-05-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-27","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"03d819968bc3f9755c999147d7585263a2744d74e9a3a68633430aca0b153a46","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2026-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-17","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"1bc64f8e8577771a3763f684b97d617b08b70983d77a3a7c9f98cc1f84c9665d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2026-07-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-07-09","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"59a2d6373504cca097e5a7f66668aed83f67c5ee3975eb280eaf2f7df4d41933","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2026-07-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-07-22","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"18ce3982feb784a548e06f0ba4dff7dc80161956489eb5b25918dd14ab579708","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=27&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"0ddfa1e2a953181624f889fd860ed5af0f622fdf1bea1ce1b487ac8ce2bcaae4"}}